Cargando…

Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy

BACKGROUND: Thyroid cancer becomes the most common endocrine cancer with the greatest growing incidence in this decade. Sorafenib is a multikinase inhibitor for the treatment of progressive radioactive iodine-refractory differentiated thyroid cancer (DTC), while the off-target toxicity effect is usu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, You, Xiang, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289230/ https://www.ncbi.nlm.nih.gov/pubmed/30584304 http://dx.doi.org/10.2147/IJN.S187240

Ejemplares similares

In vivo targeting of breast cancer with a vasculature-specific GQDs/hMSN nanoplatform
por: Dong, Jingjing, et al.
Publicado: (2019)

Preparation of core/shell CdTe@hMSN for enhanced tumor vasculature-specific drug delivery
por: Yang, Dongzhi, et al.
Publicado: (2018)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Proteasome impairment in neural cells derived from HMSN-P patient iPSCs
por: Murakami, Nagahisa, et al.
Publicado: (2017)

Safety and tolerability of sorafenib in patients with radioiodine-refractory thyroid cancer
por: Worden, Francis, et al.
Publicado: (2015)

Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy
por: Sun, Ting, et al.
Publicado: (2017)

Fe(3+)-binding transferrin nanovesicles encapsulating sorafenib induce ferroptosis in hepatocellular carcinoma
por: Xiao, Youmei, et al.
Publicado: (2023)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
por: Ling, Yuanna, et al.
Publicado: (2023)

Molecular architecture determines brain delivery of a transferrin receptor–targeted lysosomal enzyme
por: Arguello, Annie, et al.
Publicado: (2022)

SoLAT (Sorafenib Lenvatinib alternating treatment): a new treatment protocol with alternating Sorafenib and Lenvatinib for refractory thyroid Cancer
por: Kim, Soo Young, et al.
Publicado: (2018)

Targeting bacterial transferrin and lactoferrin receptors for vaccines
por: Schryvers, Anthony B.
Publicado: (2022)

Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy
por: Riaz, Muhammad Kashif, et al.
Publicado: (2019)

Rapid endocytosis of the transferrin receptor in the absence of bound transferrin
Publicado: (1985)

Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes
Publicado: (1983)

Gene Silencing of Transferrin-1 Receptor as a Potential Therapeutic Target for Human Follicular and Anaplastic Thyroid Cancer
por: Campisi, Agata, et al.
Publicado: (2020)

Transferrin Receptors in Erythropoiesis
por: Richard, Cyrielle, et al.
Publicado: (2020)

Role of transferrin, transferrin receptors, and iron in macrophage listericidal activity
Publicado: (1991)

Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein
por: Loureiro, Joana A, et al.
Publicado: (2015)

Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas
por: Koneru, Tejaswi, et al.
Publicado: (2021)

Targeting the transferrin receptor to develop erythropoietin for Alzheimer's disease
por: Sumbria, Rachita K.
Publicado: (2020)

Transferrin receptor targeting by de novo sheet extension
por: Sahtoe, Danny D., et al.
Publicado: (2021)

Targeted Delivery of siRNA to Transferrin Receptor Overexpressing Tumor Cells via Peptide Modified Polyethylenimine
por: Xie, Yuran, et al.
Publicado: (2016)

RECIST 1.1 and serum thyroglobulin measurements in the evaluation of responses to sorafenib in patients with radioactive iodine-refractory differentiated thyroid carcinoma
por: RUAN, MAOMEI, et al.
Publicado: (2013)

Targeted Delivery of Amoxicillin to C. trachomatis by the Transferrin Iron Acquisition Pathway
por: Hai, Jun, et al.
Publicado: (2016)

Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins
por: Gabold, Bettina, et al.
Publicado: (2022)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies
por: Guo, Zilong, et al.
Publicado: (2021)

Apoferritin-Encapsulated Jerantinine A for Transferrin Receptor Targeting and Enhanced Selectivity in Breast Cancer Therapy
por: Abuzaid, Haneen, et al.
Publicado: (2022)

Transferrin receptor targeting segment T7 containing peptide gene delivery vectors for efficient transfection of brain tumor cells
por: Kang, Ziyao, et al.
Publicado: (2022)

Transferrin Enhances Neuronal Differentiation
por: Pérez, María Julia, et al.
Publicado: (2023)

Transferrin‐bearing liposomes entrapping plumbagin for targeted cancer therapy
por: Sakpakdeejaroen, Intouch, et al.
Publicado: (2019)

Transferrin-binding protein complex is the receptor for transferrin uptake in Trypanosoma brucei
Publicado: (1995)

Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
por: Lai, You-Liang, et al.
Publicado: (2022)

Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.)
por: Zhang, Deshui, et al.
Publicado: (2012)

Transferrin-Targeted Liposomes in Glioblastoma Therapy: A Review
por: Kawak, Paul, et al.
Publicado: (2023)

Effective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
por: Hess, Patrick P., et al.
Publicado: (2022)

Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors
por: Urbiola, Koldo, et al.
Publicado: (2018)

Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer
por: Gao, Wei, et al.
Publicado: (2017)

Therapeutic Bispecific T-Cell Engager Antibody Targeting the Transferrin Receptor
por: Fu, Mingpeng, et al.
Publicado: (2019)

Transferrin Receptor-Targeted Nanocarriers: Overcoming Barriers to Treat Glioblastoma
por: Ramalho, Maria João, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qsprjj0t7futjeugum1mmreksc